Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

SB 516 (2025-2026)

https://ontology.bommaritollc.com/id/01a0d56a-58ec-7165-b73a-00fad010fc2e

adms:identifier	mi-legislature-measure 2025-2026/SB/516
dcterms:temporal	Michigan Legislature, 2025-2026 session
in committee	Senate Committee on Government Operations (2025-2026)
primary sponsor	Jonathan Lindsey
prov:wasDerivedFrom	evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2025-SB-0516 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2025-SB-0516 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2025-SB-0516
schema:legislationChanges	1978 PA 368
schema:legislationIdentifier	SB 516
schema:legislationJurisdiction	Michigan
schema:legislationType	bill
schema:name	Health: pharmaceuticals; ivermectin; allow over-the-counter access. Amends 1978 PA 368 (MCL 333.1101 - 333.25211 ) by adding secs. 17771 & 17771a.en
schema:sponsor	Jonathan Lindsey Aric Nesbitt Dan Lauwers Kevin Daley Roger Victory Michele Hoitenga
schema:url	https://www.legislature.mi.gov/Bills/Bill?ObjectName=2025-SB-0516
skos:prefLabel	SB 516 (2025-2026)en
status	in committee
status date	2025-09-03xsd:date